JP Morgan Chase
LOXO

JP Morgan Chase’s Loxo Oncology, Inc LOXO Stock Holding History

JP Morgan Chase’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27,000
Closed -$2.27M – 5758
2017
Q4 		$2.27M Buy
+27,000
New +$2.25M ﹤0.01% 3246

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

JP Morgan Chase's LOXO Position: Q1 2019 in Review

JP Morgan Chase sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 100,728 shares — an estimated $14.1M sold.

JP Morgan Chase first reported a position in LOXO in Q2 2015 and held it in 14 quarters. The position peaked at $28.9M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • JP Morgan Chase reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • JP Morgan Chase sold 100,728 Loxo Oncology, Inc shares in Q1 2019, an estimated $14.1M.
  • JP Morgan Chase first reported a position in Loxo Oncology, Inc in Q2 2015 and held it in 14 quarters.
  • JP Morgan Chase's Loxo Oncology, Inc position peaked at $28.9M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.